Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
出版年份 2021 全文链接
标题
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
作者
关键词
-
出版物
Science Translational Medicine
Volume 13, Issue 583, Pages eabc8980
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-03-04
DOI
10.1126/scitranslmed.abc8980
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet
- (2020) Magdalena M. Bogun et al. DIABETES CARE
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
- (2020) Teresa Quattrin et al. NEW ENGLAND JOURNAL OF MEDICINE
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
- (2019) Emily K. Sims et al. Molecular Metabolism
- Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience
- (2018) Carla J. Greenbaum et al. DIABETES
- Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
- (2018) Polly J. Bingley et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Biomarkers of islet beta cell stress and death in type 1 diabetes
- (2018) Emily K. Sims et al. DIABETOLOGIA
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
- (2018) Ana Luisa Perdigoto et al. DIABETOLOGIA
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Elevations in the Fasting Serum Proinsulin–to–C-Peptide Ratio Precede the Onset of Type 1 Diabetes
- (2016) Emily K. Sims et al. DIABETES CARE
- Time-to-Event Analysis
- (2016) Juliana Tolles et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Reduced β-cell function in early preclinical type 1 diabetes
- (2015) Maarit K Koskinen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes
- (2015) James E. Tooley et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- β Cell death and dysfunction during type 1 diabetes development in at-risk individuals
- (2015) Kevan C. Herold et al. JOURNAL OF CLINICAL INVESTIGATION
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
- (2013) Tara Ghazi et al. DIABETES CARE
- Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity
- (2013) Heli T Siljander et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
- (2012) K. C. Herold et al. DIABETOLOGIA
- Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection
- (2012) Sanyukta Rana et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice
- (2011) Eitan M. Akirav et al. DIABETES
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method
- (2010) Betty Tao et al. PLoS One
- Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset
- (2009) E. Ferrannini et al. DIABETES
- Preservation of -Cell Function in Autoantibody-Positive Youth With Diabetes
- (2009) C. J. Greenbaum et al. DIABETES CARE
- Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1
- (2009) J. M. Sosenko et al. DIABETES CARE
- C-peptide in the natural history of type 1 diabetes
- (2009) Jerry P. Palmer DIABETES-METABOLISM RESEARCH AND REVIEWS
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results
- (2008) Jeffrey L Mahon et al. PEDIATRIC DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation